• Subscriber Content Read Preview

    [image]

    Gene-Altered Apple Approved in U.S.

    The Agriculture Department approved the first genetically modified apple for sale in the U.S., reigniting debate over the safety of modified foods and whether the products should carry mandatory labels.

  • Subscriber Content Read Preview

    [image]

    Painkiller in Short Supply Following Hospira Recall

    A generic painkiller widely used in hospitals is in short supply after Hospira Inc. recalled more than 60 lots of vials due to contamination by crystal particles that could cause problems if injected into patients.

  • Subscriber Content Read Preview

    Eisai Expects Strong Sales From New Cancer Drug

    Eisai said it expects its new drug for thyroid and other cancers to bring in more than $1 billion a year by 2020.

  • Subscriber Content Read Preview

    [image]

    Measles-Vaccine Debate Hits Home at California School

    The measles outbreak and debate over vaccinations has hit close to home at Julian Charter School in California, where many parents have opted out of getting their children immunized.

  • Subscriber Content Read Preview

    [image]

    Thousands to Lose Health Insurance Over Residency Questions

    The Obama administration is cutting off health-insurance coverage under the Affordable Care Act for 200,000 people who haven’t proved that they legal reside in the U.S.

  • Subscriber Content Read Preview

    [image]

    New Questions on a Health-Law Challenger

    One of the plaintiffs in the Supreme Court case against the Affordable Care Act listed a short-term-stay motel as her address when she joined the lawsuit, potentially calling into question her basis for suing.

  • [image]

    NFL Names Chief Medical Adviser

    The NFL named Elizabeth G. Nabel, a prominent Boston cardiologist, to serve as its first chief medical adviser in its latest effort to address concerns about the health and safety of football players.

  • [image]

    CDC: U.S. Measles Cases Rise

    The number of measles cases in the U.S. this year rose 18.6% over the past week, to 121 people in 17 states, federal health officials says.

  • [image]

    Drug Making Breaks Away From Old Ways

    For decades, drug makers have used cutting-edge science to discover medicines but manufactured them using techniques dating to the days of the steam engine. Now, the industry is moving toward a major upgrade.

  • Subscriber Content Read Preview

    [image]

    Doctors Work to Ease Vaccine Fears

    Pediatricians face growing numbers of parents who question or reject vaccinations for their children. Now, public health experts are working on new ways to help these doctors hone their pitches to families.

  • Subscriber Content Read Preview

    [image]

    Smartwatch App Helps Track Glucose

    Medical-device maker DexCom is designing an app that will display readings from its diabetes glucose monitor on Apple’s smartwatch, giving the watch an early foothold in the health-care market.

  • Subscriber Content Read Preview

    [image]

    Anti-Vaccination Trends Vex Herd Immunity

    The Numbers: In light of the measles outbreak in California and other states, columnist Jo Craven McGinty takes a look at the vaccination rates needed to make the math work on the concept of herd immunity.

  • [image]

    Health-Law Challenger’s Standing Is Questioned

    The lead plaintiff in the Supreme Court battle over the health law’s insurance tax credits appears to qualify for veterans’ medical coverage, raising questions about his ability to challenge the law.

  • Subscriber Content Read Preview

    [image]

    Anthem Didn’t Encrypt Stolen Data

    Anthem stored the Social Security numbers of 80 million customers without encrypting them, the result of what a person familiar with the matter said was a balancing act between protecting info and making it useful.

  • Subscriber Content Read Preview

    [image]

    Arkansas Reaches Settlement in Cystic Fibrosis Drug Suit

    Arkansas Medicaid officials have reached a legal settlement to resolve claims the state denied patients an expensive cystic fibrosis therapy made by Vertex Pharmaceuticals because of its cost.

  • Subscriber Content Read Preview

    [image]

    FDA Commissioner to Resign

    Dr. Margaret A. Hamburg, commissioner of the U.S. Food and Drug Administration, has decided to resign from her post sometime in March, according to government officials.

  • Subscriber Content Read Preview

    [image]

    Pfizer to Buy Hospira for $16 Billion

    Pfizer agreed to buy Hospira in a $16 billion, all-cash deal that would expand the drug maker’s sales of injectable drugs and lower-priced versions of costly biotech drugs.

  • Subscriber Content Read Preview

    Teva Pharmaceuticals Profit Rises as Costs Decline

    Teva Pharmaceuticals Industries Ltd. said its profit rose in the most recent quarter as a drop in costs offset revenue declines driven in part by currency headwinds.

Health & Wellness

Research Health

Get in-depth research on Health companies, including complete news and financials, earnings estimates and more.

Dow Jones Industry Tracker - Healthcare

Follow Health News

Answers allows you to tap the knowledge of Community members. Answer a question below or ask a question.

Q: What is the best way to cut Medicare and Medicaid costs and provide affordable healthcare to most Americans?

Top Groups In Health

  • Health Journal

    Health Journal columnist Melinda Beck discusses health-care questions with readers, sources and friends.

Partner Center
An Advertising Feature